New York (AFP)

Wall Street ended close to equilibrium on Friday and down over the week in a market less and less confident about the vote on a stimulus plan in the United States, ten days before the presidential election.

Its flagship index, the Dow Jones Industrial Average (DJIA), lost 0.10% to 28,335.57 points.

The Nasdaq, with strong technological coloring, rose 0.37% to 11,548.28 points.

The extended S&P 500 index gained 0.34% to 3,465.39 points.

From Monday to Friday, the DJIA fell 0.95%, the Nasdaq by 1.05% and the S&P 500 by 0.53%.

"The market would really like to see a text before the poll," says Karl Haeling of LBBW.

The US Treasury Secretary said on Friday that there were "still considerable differences" between the positions of Republicans and Democrats in the negotiations.

"But given that the stock market does not fall much, even with the many uncertainties, this suggests that investors are waiting for the election by thinking that new stimulus measures will, at worst, be voted on next year", observes Mr. Haeling.

Based on the most recent polls, most market participants are betting Democrat Joe Biden will win over Donald Trump on November 3, but do not rule out a trend reversal or outcome challenge if the gap is weak.

Among the values ​​of the day, the title of Intel (-10.58%) tumbled after the group announced, Thursday evening, a drop in its quarterly revenues, especially on the side of contracts with companies and governments , which the micro-processor giant attributes to the pandemic.

American Express stock (-3.64%) retreated after plummeting third-quarter earnings, due to lower spending by company cardholders since the start of the pandemic, however, the vast majority of them continue to repay their debts.

Toymaker Mattel (+ 9.56%) benefited in the third quarter from solid sales of its dolls, led by Barbie, the Star Wars saga Baby Yoda plush and board games like Pictionnary.

Next week, Wall Street will closely monitor the results of the US digital giants, including Amazon, Alphabet (the parent company of Google and YouTube), Facebook and Apple, all of which will publish their results on Thursday after the close.

The Gilead laboratory (+ 0.20%) took advantage of the permanent authorization granted Thursday by the United States Medicines Agency (FDA) to its antiviral drug remdesivir for hospitalized patients of Covid-19, confirming the conditional authorization granted in May.

© 2020 AFP